Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121956462 | 12195646 | 2 | F | 201403 | 20160816 | 20160321 | 20160826 | EXP | US-BAYER-2015-491779 | BAYER | 71.00 | YR | E | F | Y | 0.00000 | 20160826 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121956462 | 12195646 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | UNK | Y | N | UNKNOWN | 0 | FILM-COATED TABLET | ||||||
| 121956462 | 12195646 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | UNK | Y | N | UNKNOWN | 0 | FILM-COATED TABLET | ||||||
| 121956462 | 12195646 | 3 | PS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Oral | 81 MG, UNK | 999999 | 81 | MG | TABLET | |||||||
| 121956462 | 12195646 | 4 | SS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | 999999 | TABLET | |||||||||||
| 121956462 | 12195646 | 5 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, UNK | U | 0 | 75 | MG | |||||||
| 121956462 | 12195646 | 6 | SS | NITROSTAT | NITROGLYCERIN | 1 | Sublingual | 0.4 MG, UNK | 0 | .4 | MG | ||||||||
| 121956462 | 12195646 | 7 | C | LYRICA | PREGABALIN | 1 | Unknown | UNK | 0 | ||||||||||
| 121956462 | 12195646 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 121956462 | 12195646 | 9 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 121956462 | 12195646 | 10 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | UNK | 0 | ||||||||||
| 121956462 | 12195646 | 11 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121956462 | 12195646 | 1 | Pulmonary embolism |
| 121956462 | 12195646 | 2 | Embolism venous |
| 121956462 | 12195646 | 3 | Pulmonary embolism |
| 121956462 | 12195646 | 4 | Deep vein thrombosis |
| 121956462 | 12195646 | 5 | Product used for unknown indication |
| 121956462 | 12195646 | 6 | Product used for unknown indication |
| 121956462 | 12195646 | 7 | Product used for unknown indication |
| 121956462 | 12195646 | 8 | Product used for unknown indication |
| 121956462 | 12195646 | 9 | Product used for unknown indication |
| 121956462 | 12195646 | 10 | Product used for unknown indication |
| 121956462 | 12195646 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121956462 | 12195646 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121956462 | 12195646 | Epistaxis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121956462 | 12195646 | 1 | 201312 | 2014 | 0 | |
| 121956462 | 12195646 | 2 | 20140327 | 20140406 | 0 |